Reprogramming and transdifferentiation for cardiovascular development and regenerative medicine: where do we stand?
Abstract Heart disease remains a leading cause of mortality and a major worldwide healthcare burden. Recent advances in stem cell biology have made it feasible to derive large quantities of cardiomyocytes for disease modeling, drug development, and regenerative medicine. The discoveries of reprogram...
Uloženo v:
| Hlavní autoři: | , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Springer Nature
2015-07-01
|
| Edice: | EMBO Molecular Medicine |
| Témata: | |
| On-line přístup: | https://doi.org/10.15252/emmm.201504395 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|